194 related articles for article (PubMed ID: 10692680)
1. Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection?
Martinelli AL; Franco RF; Villanova MG; Figueiredo JF; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Zago MA
Acta Haematol; 2000; 102(3):152-6. PubMed ID: 10692680
[TBL] [Abstract][Full Text] [Related]
2. The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C.
Thorburn D; Curry G; Spooner R; Spence E; Oien K; Halls D; Fox R; McCruden EA; MacSween RN; Mills PR
Gut; 2002 Feb; 50(2):248-52. PubMed ID: 11788568
[TBL] [Abstract][Full Text] [Related]
3. HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload.
Remacha AF; Carrasco M; Sardá MP; Barceló MJ; Baiget M
Haematologica; 1999 Mar; 84(3):284-5. PubMed ID: 10189401
[No Abstract] [Full Text] [Related]
4. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
[TBL] [Abstract][Full Text] [Related]
5. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
[TBL] [Abstract][Full Text] [Related]
7. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
8. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
[TBL] [Abstract][Full Text] [Related]
9. Role of hemochromatosis genes in chronic hepatitis C.
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R; Baldassarre R
Clin Ter; 2006; 157(1):61-8. PubMed ID: 16669553
[TBL] [Abstract][Full Text] [Related]
10. Interpretation of iron studies in adolescent haemochromatosis.
Catterson PR; Summerfield GP; Beesley JR
Clin Lab Haematol; 1999 Apr; 21(2):129-31. PubMed ID: 10342073
[TBL] [Abstract][Full Text] [Related]
11. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
[TBL] [Abstract][Full Text] [Related]
12. HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis.
Ladero JM; Ropero P; Ortega L; Taxonera C; González FA; López-Alonso G; Briceño O; Rodríguez-Agulló JL; González L; Villegas A; Díaz-Rubio M
Rev Esp Enferm Dig; 2003 Dec; 95(12):829-36. PubMed ID: 14972004
[TBL] [Abstract][Full Text] [Related]
13. Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations.
Pirisi M; Scott CA; Avellini C; Toniutto P; Fabris C; Soardo G; Beltrami CA; Bartoli E
Am J Clin Pathol; 2000 Apr; 113(4):546-54. PubMed ID: 10761457
[TBL] [Abstract][Full Text] [Related]
14. The influence of hemochromatosis mutations on iron overload of thalassemia major.
Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
[TBL] [Abstract][Full Text] [Related]
15. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
[TBL] [Abstract][Full Text] [Related]
16. Frequency and influence of hemochromatosis gene mutations in kidney transplant recipients with or without hepatitis C virus infection.
Ramírez E; Pacho A; Morales JM; De Castro I; Paz-Artal E; Morales P
Transplant Proc; 2009; 41(6):2422-4. PubMed ID: 19715939
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls.
Sánchez M; Bruguera M; Bosch J; Rodés J; Ballesta F; Oliva R
J Hepatol; 1998 Nov; 29(5):725-8. PubMed ID: 9833909
[TBL] [Abstract][Full Text] [Related]
18. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.
Sikorska K; Stalke P; Romanowski T; Rzepko R; Bielawski KP
Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):377-84. PubMed ID: 23924495
[TBL] [Abstract][Full Text] [Related]
19. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload.
Townsend A; Drakesmith H
Lancet; 2002 Mar; 359(9308):786-90. PubMed ID: 11888608
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of 5 patients with possible primary hemochromatosis].
Jacobs EM; de Vries RA; Elving LD; Stalenhoef AF; Swinkels DW
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):666-70. PubMed ID: 12712652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
